☆ 4.8 Article

Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma

CANCER RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

Metabolic programming and immune suppression in the tumor microenvironment

Emily N. Arner et al.

Summary: Increased glucose metabolism and uptake are characteristic of many tumors and used clinically to diagnose and monitor cancer progression. Cooperation and competition between different cell populations within the tumor microenvironment (TME) drive tumor proliferation, progression, metastasis, and immune evasion. Targeting metabolic heterogeneity within the TME may offer therapeutic opportunities to overcome immune suppression and enhance immunotherapies.

CANCER CELL (2023)

Add to Collection

Article Oncology

Tumor-immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas

Tanya T. D. Soeratram et al.

Summary: Immunotherapy as a new treatment option for cancer has shown promising results in clinical trials. By investigating immune landscape patterns in esophageal adenocarcinoma (EAC) patients, a correlation was found between pretreatment immune cell densities and response to neoadjuvant chemoradiation (nCRT), suggesting potential for future immune therapeutic strategies.

JOURNAL OF PATHOLOGY (2022)

Add to Collection

Review Immunology

Immunogenic cell stress and death

Guido Kroemer et al.

Summary: Immunogenic cell death (ICD) plays an important role in therapy and disease, as dying mammalian cells release signals that interact with the host to determine the immunological correlates of cellular stress and death. ICD is crucial in immunosurveillance and is related to strategies evolved by pathogens and cancer cells. Additionally, normal cell death can also initiate antigen-specific immune responses.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Functional role of the SLC7A11-AS1/xCT axis in the development of gastric cancer cisplatin-resistance by a GSH-dependent mechanism

Yajun Luo et al.

Summary: This study reveals the involvement of SLC7A11-AS1 and xCT in cisplatin resistance in gastric cancer. Downregulation of SLC7A11-AS1 and upregulation of xCT are associated with poor prognosis and chemotherapy response. Overexpression of SLC7A11-AS1 suppresses gastric cancer cell growth and enhances sensitivity to cisplatin.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Add to Collection

Article Oncology

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

R. Obermannova et al.

ANNALS OF ONCOLOGY (2022)

Add to Collection

Article Immunology

A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes

Leire Pedrosa et al.

Summary: In this study, researchers developed an immune-metabolic signature suitable for personalized immune checkpoint inhibitor therapies. The signature classified tumors into three distinct immune-metabolic clusters, providing a new predictive tool for patient selection for specific immune-metabolic therapeutic approaches.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Biology

Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+T cells in luminal-like breast cancer

Agnese Losurdo et al.

Summary: By analyzing breast cancer-infiltrating T cells using high-dimensional single-cell technologies, researchers found that a small subset of tissue-resident memory CD8+ T cells with enhanced degranulation capacity is associated with positive prognosis in luminal-like breast cancer, highlighting the potential importance of specific T cell immune microenvironment.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection

Article Oncology

Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

Tom van den Ende et al.

Summary: The study demonstrated the feasibility of combining nCRT with PD-L1 inhibition for patients with rEAC. Most patients proceeded to surgery after receiving all cycles of atezolizumab, and some experienced immune-related adverse events. Exploratory biomarker analysis suggested the potential of neoadjuvant immunotherapy in certain patient subgroups.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody

James J. Harding et al.

Summary: The study evaluated the safety and effectiveness of the TIM-3 monoclonal antibody LY3321367 in patients with advanced solid tumors and determined the recommended dosage. Results showed that LY3321367 had acceptable safety and favorable pharmacokinetics, but only modest antitumor activity.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Review Immunology

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

Karthik Dhatchinamoorthy et al.

Summary: Loss of MHC I antigen presentation is common in many cancers, which may impair immune responses and affect the efficacy of immunotherapy. Studies have discussed underlying mechanisms through which some cancers evade immune killing by shutting down the MHC I pathway, and proposed potential strategies to overcome this limitation.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly et al.

Summary: In patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, adjuvant therapy with nivolumab significantly improved disease-free survival compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Cell Biology

Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling

Hui Liu et al.

Summary: Tumor recurrence is a major obstacle for liver transplantation in HCC patients, with inflammatory cascades promoting recurrence. The mobilization of MDSC induced by liver graft injury plays a role in promoting HCC recurrence. Targeting MDSC mobilization via CXCL10/TLR4/MMP14 signaling may represent a potential therapeutic approach to decrease post-transplant liver tumor recurrence.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Multidisciplinary Sciences

A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells

Zijun Wang et al.

Summary: LCP2 expression is upregulated in metastatic skin cutaneous melanoma and associated with good overall survival. It is involved in multiple immune response pathways and positively correlated with molecules in TCR signaling and immune checkpoints in melanoma. High LCP2 expression is positively correlated with tumor-infiltrating CD8(+) T cells and acts as a prognostic biomarker for progression-free survival in patients receiving anti-PD1 immunotherapy.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence

Geraldine Luis et al.

Summary: The study revealed that SCD1 and FABP4 play essential roles in tumor recurrence by enhancing antioxidant and anti-ferroptotic resources. Inhibiting lipid transport and targeting SCD1 can effectively reduce tumor regrowth.

REDOX BIOLOGY (2021)

Add to Collection

Article Oncology

Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma

Fereshteh Izadi et al.

Summary: Esophageal adenocarcinoma (EAC) patients receive pre-operative chemotherapy, but a significant portion do not respond to this treatment, exhibiting chromosomal instability and gene copy number alterations. Different genetic profiles, including mutations in the tumor suppressor NAV3, are associated with non-responders, presenting potential drug targets for alternative treatment pathways.

CANCERS (2021)

Add to Collection

Review Oncology

Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade

Tian Tian et al.

Summary: Blocking therapy targeting programmed death receptor 1 (PD-1) or programmed death ligand 1 (PD-L1) has revolutionized the treatment of malignant tumors, but patient response rates are low and drug resistance is a major concern. Combining this therapy with Tim-3 blockade may offer a promising approach to overcoming resistance in cancer immunotherapy.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Progesterone receptor gene serves as a prognostic biomarker associated with immune infiltration in gastric cancer: a bioinformatics analysis

Manyu Li et al.

Summary: The study revealed that elevated PGR expression is associated with poor prognosis in gastric cancer patients and is related to immune cell infiltration.

TRANSLATIONAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

LncRNA TUSC8 suppresses the proliferation and migration of esophageal cancer cells by downregulation of VEGFA

Rui Hu et al.

Summary: This study demonstrates that the long non-coding RNA TUSC8 is downregulated in esophageal cancer tissues and cell lines, and it inhibits the proliferative and migratory abilities in esophageal cancer cells by negatively regulating VEGFA.

JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma

R. S. A. Goedegebuure et al.

Summary: In-depth analysis revealed a close relationship between the levels and distribution of T cells and the response to neoadjuvant CRT in esophageal adenocarcinoma patients. The presence of memory T cells in peripheral blood T cells contributes to a complete pathological response to CRT.

ONCOIMMUNOLOGY (2021)

Add to Collection

Review Oncology

Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance

Marina Bacci et al.

Summary: Lipid metabolic reprogramming plays a significant role in influencing the response to antitumoral therapies and sustaining resistance. Aberrant lipid metabolism has emerged as a potential vulnerability in therapy-resistant cancers.

TRENDS IN CANCER (2021)

Add to Collection

Article Cell Biology

The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2-Breast Cancer

Masanori Oshi et al.

CELLS (2020)

Add to Collection

Review Oncology

Metabolism of immune cells in cancer

Robert D. Leone et al.

NATURE REVIEWS CANCER (2020)

Add to Collection

Article Surgery

C5aR1 regulates migration of suppressive myeloid cells required for costimulatory blockade-induced murine allograft survival

Ines Llaudo et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

Add to Collection

Article Gastroenterology & Hepatology

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

Richard C. Turkington et al.

GUT (2019)

Add to Collection

Article Immunology

CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer

Laura M. McLane et al.

Annual Review of Immunology (2019)

Add to Collection

Article Cell Biology

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

Xingzhe Ma et al.

CELL METABOLISM (2019)

Add to Collection

Article Genetics & Heredity

Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system

Claire Lhuillier et al.

GENOME MEDICINE (2019)

Add to Collection

Article Cell Biology

Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53

Yajie Chen et al.

CELL DEATH & DISEASE (2019)

Add to Collection

Article Oncology

Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11

Xueting Lang et al.

CANCER DISCOVERY (2019)

Add to Collection

Article Multidisciplinary Sciences

FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy

Jun Iwabu et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Oncology

Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers

Oliver M. T. Pearce et al.

CANCER DISCOVERY (2018)

Add to Collection

Article Oncology

Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro

Waleed Al-Khyatt et al.

BMC CANCER (2018)

Add to Collection

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

Add to Collection

Article Multidisciplinary Sciences

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

Thomas Duhen et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Peroxisomes and cancer: The role of a metabolic specialist in a disease of aberrant metabolism

Michael S. Dahabieh et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Add to Collection

Article Cell Biology

The novel immunoglobulin super family receptor SLAMF9 identified in TAM of murine and human melanoma influences pro-inflammatory cytokine secretion and migration

Claudia Dollt et al.

CELL DEATH & DISEASE (2018)

Add to Collection

Article Gastroenterology & Hepatology

T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes

Daniele Mennonna et al.

GUT (2017)

Add to Collection

Article Immunology

Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes

Silvia Cerboni et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Add to Collection

Article Medicine, General & Internal

Oesophageal cancer

Elizabeth C. Smyth et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Nicholas McGranahan et al.

CELL (2017)

Add to Collection

Article Gastroenterology & Hepatology

C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits

Lan Wang et al.

GASTROENTEROLOGY (2016)

Add to Collection

Review Cell Biology

Keratins in health and disease

Diana M. Toivola et al.

CURRENT OPINION IN CELL BIOLOGY (2015)

Add to Collection

Article Oncology

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joel Shapiro et al.

LANCET ONCOLOGY (2015)

Add to Collection

Article Oncology

The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy

Ying-En Lee et al.

TUMOR BIOLOGY (2015)

Add to Collection

Review Biotechnology & Applied Microbiology

The secret ally: immunostimulation by anticancer drugs

Lorenzo Galluzzi et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Add to Collection

Review Oncology

The immune contexture in human tumours: impact on clinical outcome

Wolf Herman Fridman et al.

NATURE REVIEWS CANCER (2012)

Add to Collection

Article Multidisciplinary Sciences

Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21

Jacqueline D. Shields et al.

SCIENCE (2010)

Add to Collection

Article Cell Biology

Coordination of Receptor Signaling in Multiple Hematopoietic Cell Lineages by the Adaptor Protein SLP-76

Martha S. Jordan et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival

James M. Donahue et al.

ANNALS OF THORACIC SURGERY (2009)

Add to Collection

Article Hematology

Role of GM-CSF signaling in cell-based tumor immunization

Shohreh Zarei et al.

BLOOD (2009)

Add to Collection

Article Immunology

IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients

Susanna Mandruzzato et al.

JOURNAL OF IMMUNOLOGY (2009)

Add to Collection

Review Biochemistry & Molecular Biology

The Bcl-2 family: roles in cell survival and oncogenesis

S Cory et al.

ONCOGENE (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.